Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.
about
Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapiesMonoamine Oxidases as Potential Contributors to Oxidative Stress in Diabetes: Time for a Study in Patients Undergoing Heart SurgeryDiurnal rhythms of serum and plasma cytokine profiles in healthy elderly individuals assessed using membrane based multiplexed immunoassay.Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO MiceThe Importance of NLRP3 Inflammasome in Heart FailureLife Course Socioeconomic Position: Associations with Cardiac Structure and Function at Age 60-64 Years in the 1946 British Birth Cohort.HMGB1-RAGE Axis Makes No Contribution to Cardiac Remodeling Induced by Pressure-OverloadAntihypertensive medications and diastolic dysfunction progression in an African American population.Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure.Cardiovascular function, compliance, and connective tissue remodeling in the turtle, Trachemys scripta, following thermal acclimationInterleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Heart failure with preserved ejection fraction: Defining the function of ROS and NO.A Central Role for Monocyte-Platelet Interactions in Heart Failure.The proinflammatory cytokine tumor necrosis factor-α excites subfornical organ neurons.Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.Myocardial reverse remodeling: how far can we rewind?Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study.Heart failure with preserved ejection fraction: a nephrologist-directed primer.Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.Surgical Acute Volume-Overload Impacts Early on Myocardium - An Experimental Study.C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.Immune mechanisms in heart failure.Inflammatory responses and inflammation-associated diseases in organs.Synthetic Fluororutaecarpine Inhibits Inflammatory Stimuli and Activates Endothelial Transient Receptor Potential Vanilloid-Type 1.Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis.Regulation of TLR4 expression mediates the attenuating effect of erythropoietin on inflammation and myocardial fibrosis in rat heart.Inflammation in Right Ventricular Failure: Does It Matter?
P2860
Q27000263-D9D521FA-590A-498A-9A0F-C633AAFF8986Q28395925-B8E76572-F9E0-491F-959B-921A9F18270CQ35552567-EA67083B-B29F-475D-B627-0FA7397853C7Q35804806-3C035CB2-AF41-4F45-A340-DF48DA73B2A3Q35891957-118ABF49-D117-413F-BA47-44EB922AAE7EQ35975461-3FC97884-C0A5-4A7A-9592-1F00A4B1343FQ36063836-88FE349D-99A3-4F02-AD59-02CFB22A491FQ36463057-003F195F-33D0-4282-9FD0-675714BED267Q36885431-49993326-5742-4EE9-B27C-9391DDF6992CQ37139704-46A2B911-04F9-41D3-8559-68B5F0CC9B1AQ38183314-F2DC5728-BA03-4A1F-93AD-9198FDD320A3Q38482322-93594E22-BA04-45C6-9A6E-7EB3C031755FQ38620927-1DA30BC3-3EA2-4A6D-A649-719908640436Q38715009-0AD807BC-1746-4B75-865A-C58AF54977DEQ38727741-59AC9EA5-522B-4A5E-8D15-85CDB6DE8FCFQ38764956-C272D0BA-7807-4F5F-9AF7-5B66522B5A79Q38780883-867EA246-A802-47FB-84DC-95512DEC7D06Q39010896-372B4170-8515-4E88-B82F-13A28FA16B23Q39301622-21C783A1-6E2E-4A21-9730-AB5D53A93057Q40286144-7D49A06D-3519-4684-917B-B66309193CA8Q47141196-BEA3064B-55C2-4343-B644-88ABEDD5AA24Q48787655-D2B687BB-3836-4474-A85A-AC90C5166914Q50168083-0EA35CAE-9D6A-46B9-BBB9-376EB4AD3864Q50281561-CE4D7C0F-CC21-48E8-A7C6-E8EE40C56258Q50910868-D4B9F60D-0AB2-44CA-8A91-A19649CF22D6Q53337186-9EE9567E-AFD6-4D70-B56A-341FFD1D008EQ54977728-2DE5B5D9-C8BB-4FBB-BB18-4D3E8619B3E3Q58735426-A254994D-F993-427A-A2AC-A495DDEE5D4B
P2860
Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of inflammation in the pa ...... ntial as a therapeutic target.
@en
type
label
Role of inflammation in the pa ...... ntial as a therapeutic target.
@en
prefLabel
Role of inflammation in the pa ...... ntial as a therapeutic target.
@en
P2860
P1476
Role of inflammation in the pa ...... ntial as a therapeutic target.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10741-013-9405-8
P577
2014-09-01T00:00:00Z